GRITSTONE BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8134 USD | +6.40% |
|
+10.43% | -60.13% |
| 15/04 | Nature Medicine Publishes Interim Results from Gritstone Bio's Phase 1/2 Study of "Off-The-Shelf" Neoantigen Vaccine Platform | CI |
| 02/04 | Top Midday Decliners | MT |
Chart calendar Gritstone bio, Inc.
9531e91c8b4700ecdcf141d4.F9Ntq9aKdG-t0APLnj_G4lKpLExeGkZNAoIT7ufNIFg.bbQ-75j5OSX-4GXz2wmNvRHAVhUaSQ0LR8x_oZGFDSJm5l3Ru8ECOvSUdA~ecd64568408dbd523645816553eab0a4
Upcoming events on Gritstone bio, Inc.
Past events on Gritstone bio, Inc.
| 24/04/2024 01:35 pm | Cambridge Healthtech Institute Immuno-Oncology Summit |
| 15/04/2024 08:30 pm | CG Horizons in Oncology Virtual Conference - Panel |
| 09/04/2024 08:30 pm | Needham Virtual Healthcare Conference |
| 09/04/2024 12:30 am | American Association for Cancer Research Meeting - Abstract 904 |
| 03/04/2024 06:40 pm | World Vaccine Congress - Panel |
| 06/03/2024 02:35 am | Q4 2023 Earnings Release |
| 04/03/2024 09:00 pm | TD Cowen Health Care Conference - Panel |
| 28/02/2024 01:00 am | IO360 Summit - Panel |
| 27/02/2024 12:30 am | BIO Ceo & Investor Conference - Panel |
| 19/01/2024 12:00 am | B. Riley Securities Oncology Conference - Track 2 |
| 05/12/2023 09:30 pm | Goldman Sachs Catalyst Clinic Meeting |
| 30/11/2023 08:30 pm | Piper Sandler Healthcare Conference |
| 29/11/2023 08:30 pm | Evercore ISI HealthCONx Conference |
| 09/11/2023 02:35 am | Q3 2023 Earnings Release |
| 18/10/2023 03:30 am | BIO Investor Forum |
| 14/10/2023 09:45 pm | IDWeek Conference - Abstract : 1530224 |
| 14/10/2023 09:45 pm | IDWeek Conference - Abstract No. - 1530224 |
| 14/10/2023 09:45 pm | IDWeek Conference - Abstract : 1538194 |
| 09/10/2023 | JonesTrading Healthcare Summit |
| 28/09/2023 11:55 pm | Cantor Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,37 4,56 -4.35% | 4,04 3,89 3.73% | 48,2 48,0 0.39% | 19,9 18,6 7.3% | 16,3 11,1 46.74% | 37,4 |
|
EBITDA Million USD | Released Forecast Spread | -93,2 -93,5 0.33% | -99,4 -103 3.13% | -68,9 -65,8 -4.72% | -114 -113 -0.46% | -132 -139 5.19% | -163 |
|
EBIT Million USD | Released Forecast Spread | -97,9 -95,4 -2.63% | -106 -107 0.58% | -75,2 -73,7 -2.07% | -120 -120 -0.56% | -140 -146 4.31% | -131 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -94,4 -93,0 -1.53% | -105 -105 -0.25% | -75,1 -73,9 -1.55% | -120 -120 -0.08% | -138 -145 4.2% | -125 |
|
Net income Million USD | Released Forecast Spread | -94,4 -93,0 -1.53% | -105 -105 -0.25% | -75,1 -73,9 -1.55% | -120 -120 -0.08% | -138 -145 4.2% | -125 |
|
EPS USD | Released Forecast Spread | -2,81 -2,63 -6.71% | -2,79 -2,71 -2.83% | -0,95 -1,08 12.04% | -1,32 -1,42 6.71% | -1,20 -1,29 7.18% | -1,01 |
| Announcement Date | 11/03/20 | 11/03/21 | 10/03/22 | 09/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,06 2,86 7.04% | 7,19 4,21 70.71% | 5,47 3,19 71.38% | 3,02 3,61 -16.27% | 4,26 2,90 46.83% | 2,44 3,17 -22.85% | 1,96 2,47 -20.79% | 1,57 2,21 -29.17% | 10,4 4,56 127.8% | 3,26 | 3,26 | 10,1 | 17,3 | 75,5 |
|
EBIT Million USD | Released Forecast Spread | -29,8 -28,3 -5.39% | -29,0 -30,5 5.18% | -29,7 -31,3 5.18% | -29,9 -32,0 6.77% | -31,9 -31,3 -2.12% | -34,8 -33,6 -3.54% | -35,7 -35,6 -0.35% | -38,6 -36,4 -6.16% | -30,5 -35,0 12.94% | -35,7 | -35,0 | -37,2 | -37,3 | -29,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -29,8 -28,6 -3.99% | -28,9 -30,5 5.19% | -29,5 -31,6 6.56% | -30,0 -31,6 5.2% | -31,3 -31,2 -0.24% | -34,0 -32,9 -3.29% | -35,3 -35,4 0.3% | -38,4 -37,4 -2.67% | -30,8 -36,7 16.08% | -35,1 | -34,1 | -34,8 | -35,0 | -30,3 |
|
Net income Million USD | Released Forecast Spread | -29,8 -28,6 -3.99% | -28,9 -30,5 5.19% | -29,5 -31,6 6.56% | -30,0 -31,6 5.2% | -31,3 -31,2 -0.24% | -34,0 -32,9 -3.29% | -35,3 -35,4 0.3% | -38,4 -37,4 -2.67% | -30,8 -36,7 16.08% | -35,1 | -34,1 | -34,8 | -35,0 | -30,3 |
|
EPS USD | Released Forecast Spread | -0,36 -0,40 9.24% | -0,34 -0,36 5.56% | -0,34 -0,41 17.07% | -0,35 -0,40 11.95% | -0,30 -0,35 14.89% | -0,30 -0,34 11.76% | -0,31 -0,36 12.92% | -0,33 -0,36 7.3% | -0,26 -0,33 20.87% | -0,32 | -0,27 | -0,24 | -0,24 | -0,22 |
| Announcement Date | 10/03/22 | 05/05/22 | 04/08/22 | 03/11/22 | 09/03/23 | 11/05/23 | 09/08/23 | 08/11/23 | 05/03/24 | - | - | - | - | - |
More events
Past sector events for Gritstone bio, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GRTS Stock
- Calendar Gritstone bio, Inc.
